Physician profile
William C Kethman
NPI 1083970834
$27,244.47
in general payments reported to CMS, 2019-2025
14 companies · $24K in 2025
The $24K reported for 2025 was more than what 98% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $473 · 2021: $243 · 2022: $605 · 2023: $122 · 2024: $2,134 · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Travel and Lodging: $2,558 · Food and Beverage: $1,949.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $21,416.04 |
| Travel and Lodging | $2,557.78 |
| Food and Beverage | $1,949.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ethicon Endo-Surgery INC. | $21,724.22 | 2025 | Enseal, Harmonic, Echelon Flex |
| Boston Scientific Corporation | $1,581.64 | 2020-2024 | Orise |
| Medical Device Business Services, INC. | $1,500.29 | 2025 | |
| Medtronic, INC. | $785.15 | 2021-2025 | Interstim |
| Ethicon US, LLC | $514.22 | 2021-2025 | Vistaseal, Ethicon, Stratafix |
| Intuitive Surgical, INC. | $327.70 | 2020 | |
| Pentax of America, INC. | $242.68 | 2024 | Pentax Medical, C2 Cryoballoon, Inspira |
| Axonics, INC. | $149.73 | 2024 | Axonics |
| Guard Medical INC. | $138.74 | 2024 | Npseal Large |
| Dilon Technologies, INC. | $95.74 | 2024-2025 | Hemoblast Bellows |
| Vertex Pharmaceuticals Incorporated | $86.72 | 2025 | |
| Applied Medical Resources Corporation | $42.58 | 2025 | |
| Vioptix INC | $42.23 | 2022 | |
| Abbvie INC. | $12.83 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Kethman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.